Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

adult acute lymphoblastic leukemia - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

adult acute lymphoblastic leukemia

MONDO:0003541

Also known as:acute lymphoblastic leukaemia (ALL)acute lymphoblastic leukemia (ALL)adult ALL

Find Clinical TrialsTrials

Overview

An acute lymphoblastic leukemia occurring during adulthood.

TreatmentsNo approved treatments · 10 in pipeline

Clinical Trials31 registered · 8 recruiting

Diagnosis

Biomarker and diagnostic research for adult acute lymphoblastic leukemia has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for adult acute lymphoblastic leukemia. An additional 10 compounds hold orphan drug designation.

Orphan Drug Designations

While no drugs are FDA-approved specifically for adult acute lymphoblastic leukemia, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.

The following drugs have received orphan drug designation from the FDA for adult acute lymphoblastic leukemia. Orphan designation reflects regulatory interest and does not indicate approval for treatment.

Brand Name	Generic Name	Sponsor

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

31 clinical trials registered, 8 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 8 PHASE2, 9 PHASE1, 4 NA. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT02872987](https://clinicaltrials.gov/study/NCT02872987)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Patient Support

Financial & Access Support (External Programs)

View all programs →

Acute Lymphoblastic Leukemia Program

Premium/CopayClosedOperated by Good Days

Visit official site

Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.

Are you a patient organization for this condition?

Claim this page and your organization will be listed here for patients and families to find.

Be recognized as the official organization
Get notified of new trials, FDA decisions, and research
Appear in the disease page directory
Embed this content on your website — free

Medical References

Questions for Your Care Team

→Are any of the 31 active clinical trials a good fit for my situation?
→With 10 compounds in the orphan drug pipeline, which are furthest along in development and which clinical trials should I be aware of?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	98	35%
Disease patterns and progression	50	18%
Laboratory research	42	15%
Clinical study results	41	15%
Patient case studies	20	7%
Testing and diagnosis research	14	5%
New treatment approaches	9	3%
Other research	4	1%

adult acute lymphoblastic leukemia

Overview

Diagnosis

Treatment

Orphan Drug Designations

Research Landscape

Patient Support

Financial & Access Support (External Programs)

Are you a patient organization for this condition?

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications